Benny Ward, a former executive with Closure Medical, is the new chief financial officer at Interventional Rhythm Management.

Ward served as CFO at Closure from March of 2000 until it was sold to Johnson & Johnson last year. He had served earlier as controller. Ward worked with Daniel Pelak, now the CEO of Interventional Rhythm Management, who was also CEO of Closure.

“We are privileged to attract a veteran medical device CFO like Benny to our organization,” Pelak said in a statement. “He brings a wealth of experience and solid credentials to our team. His leadership, professional acumen and relationships with members of the financial community make him an ideal fit for the position.

Interventional Rhythm Management, which has raised $35.2 million in financing, is developing technology for use in cardiac rhythm management.